BRL 37344 sodium
CAS No. 127299-93-8
BRL 37344 sodium ( BRL37344 sodium )
产品货号. M11141 CAS No. 127299-93-8
BRL 37344 is a potent and selective β3 adrenoceptor agonist with Ki of 287 nM; has weaker binding affinity for β1 and β2 receptors with Ki of 1750 and 1120 nM, respectively.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
50MG | ¥6164 | 有现货 |
|
100MG | ¥9315 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称BRL 37344 sodium
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述BRL 37344 is a potent and selective β3 adrenoceptor agonist with Ki of 287 nM; has weaker binding affinity for β1 and β2 receptors with Ki of 1750 and 1120 nM, respectively.
-
产品描述BRL 37344 is a potent and selective β3 adrenoceptor agonist with Ki of 287 nM; has weaker binding affinity for β1 and β2 receptors with Ki of 1750 and 1120 nM, respectively; A potent agonist in brown adipocytes (EC50 = 3.3 +/- 0.8 nM) than in white adipocytes (EC50=5.7 nM) or colon (EC50=27.5 nM); Stimulates fuel oxidation by soleus muscle in vitro.Diabetes Discontinued
-
同义词BRL37344 sodium
-
通路Angiogenesis
-
靶点Adrenergic Receptor
-
受体Adrenergic Receptor
-
研究领域Metabolic Disease
-
适应症Diabetes
化学信息
-
CAS Number127299-93-8
-
分子量385.82
-
分子式C19H21NO4ClNa
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC(CC1=CC=C(C=C1)OCC(=O)[O-])NCC(C2=CC(=CC=C2)Cl)O.[Na+]
-
化学全称Rel-2-[4-[(2S)-2-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]-acetic acid, monosodium salt
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Arch JR, et al. Nature. 1984 May 10-16;309(5964):163-5.
2. Oriowo MA, et al. J Pharmacol Exp Ther. 1996 Apr;277(1):22-7.
3. Board M, et al. Eur J Pharmacol. 2000 Oct 6;406(1):33-40.
2. Oriowo MA, et al. J Pharmacol Exp Ther. 1996 Apr;277(1):22-7.
3. Board M, et al. Eur J Pharmacol. 2000 Oct 6;406(1):33-40.
产品手册
关联产品
-
Xamoterol
Xamoterol (ICI 118587) is a third-generation adrenergic β1 adrenergic receptor partial agonist that acts as a cardiac stimulant.
-
Vilanterol trifenata...
Vilanterol trifenatate is a long-acting agonist of β2-adrenoceptor (β2-AR) with inherent 24-hour activity(β2-AR, β1-AR and β3-AR pEC50s of 10.37, 6.98 and 7.36, respectively).
-
Lutein
Lutein has antitumour action, is potentially useful for treating macular degeneration.